Arkansas recalls

Arrow International recalled multiple PSI and MAC catheter kits because they contain lidocaine, bupivacaine, and saline from a supplier with quality issues. The supplier's products may not be sterile, and there have been limited reports that the medications did not work as expected. If the sterility of these injectable products is compromised, patients could experience serious or life-threatening infections.

Arrow International's ACCESS TRAY kits (model ASK-04001-MC3) contain injectable anesthetic and saline solutions from a supplier with documented quality issues. If the sterility of these water-based injectables has been compromised, serious or life-threatening infections could result. The supplier also reported limited cases of drug ineffectiveness.

Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with documented quality problems in multiple arterial catheter kits and sets. The supplier's medications showed signs of ineffectiveness, and if sterility was compromised, the kits could cause serious injury when used.

Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with quality issues in three central access kits. The supplier's quality problems and limited reports of drug ineffectiveness raise concerns that sterility may be compromised, which could lead to serious infection or other life-threatening complications.

Arrow International included injectable medications (lidocaine, bupivacaine, and sodium chloride) from a supplier with quality issues in multiple spinal anesthesia kits. The supplier's products may not be sterile or effective, which could cause serious injury during spinal procedures.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple hemodialysis and AHDC kits. The supplier's products have been linked to drug ineffectiveness and potential sterility failures. Compromised sterility in injectable products can cause serious or life-threatening infections.

Arrow International included anesthetic and saline solutions from a supplier with documented quality issues in PI Midline midline catheter kits. The supplier's products showed signs of ineffectiveness and potential sterility problems, which could compromise the safety of these injectable medical devices.

Arrow International included anesthetic drugs (lidocaine and bupivacaine) and saline solution from a supplier with quality problems into paracentesis kits. The supplier had reports of drug ineffectiveness, and if the sterility of these injectable products was compromised, patients could face serious injury.

Arrow International included injectable anesthetic and saline solutions from a supplier with quality issues in multiple central venous catheter kits and trays. The supplier's products may not be sterile or may not work as intended. If sterility is compromised, these injectable products could cause serious infection or other life-threatening complications.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple central venous catheter kits. The supplier's components may not be sterile or effective, which could cause serious infection or treatment failure in patients receiving these kits.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in pacing/PSI kits. The supplier's products had limited reports of drug ineffectiveness, and if the sterility of these injectable products is compromised, it could cause serious or life-threatening injury. Approximately 95 kits were distributed nationwide.

Arrow International included anesthetic medications (lidocaine and bupivacaine) and saline solution from a supplier with quality issues in multiple drainage, thoracentesis, and pneumothorax kits. If these injectable products lost sterility during manufacturing or storage, they could cause serious infection or treatment failure.

Arrow International hemodialysis kits contain anesthetic and saline solutions from a supplier with quality control problems and reports of drug ineffectiveness. If the sterility of these injectable products is compromised, patients could face serious or life-threatening complications.

Arrow International's 8FR peritoneal lavage catheter kits contain anesthetic medications (lidocaine and bupivacaine) from a supplier with known quality issues. If the sterility of these injectable components is compromised, patients could face serious injury or infection.

Arrow International JACC catheter kits contain lidocaine, bupivacaine, and sodium chloride from a supplier with quality control problems. The injectable components may not work properly or could be sterile-compromised, risking serious infection if used.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple PICC and JACC catheter kits. The anesthetic and saline components may be ineffective or contaminated, which could cause serious infection or other life-threatening complications if used.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple catheter and arterial line kits. The supplier's products showed signs of ineffectiveness and potential sterility problems, which could cause serious harm if compromised injectable products are used.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality problems in multiple central venous catheter kits. The supplier's products had reports of ineffectiveness, and if sterility is compromised, these injectable drugs could cause serious infection or other life-threatening complications.

Arrow International included anesthetic and saline components from a supplier with quality issues in several percutaneous central venous catheter (CVC) kits. The supplier's products showed limited reports of drug ineffectiveness, and compromised sterility in injectable products could cause serious injury.

Arrow International included injectable medications (lidocaine, bupivacaine, and sodium chloride) from a supplier with quality issues in several catheter kit models. If the sterility of these water-based injectable products is compromised, patients could face serious or life-threatening infections.

Arrow International hemodialysis kits contain lidocaine, bupivacaine, and saline solution from a supplier with quality control problems. The contaminated materials may not work as intended, and compromised sterility in injectable products could cause serious harm to patients.

Arrow International included injectable medications (lidocaine, bupivacaine, and sodium chloride) from a supplier with quality problems into hemodialysis kits. The supplier's products may not be sterile or effective, which could cause serious injury if used.

Arrow International included anesthetic medications (lidocaine, bupivacaine) and saline from a supplier with quality issues in multiple epidural catheter kits. The supplier's products may not be sterile or effective, and compromised sterility in injectable products can cause serious infection or other life-threatening complications.

Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple PICC (peripherally inserted central catheter) kit models. The supplier's products may be ineffective or contaminated, and compromised sterility in injectable products can cause serious infection or injury.

Arrow International recalled multiple central venous catheter kits that contain lidocaine, bupivacaine, and saline solution from a supplier with quality issues. The supplier's products may have compromised sterility, which could reduce drug effectiveness and pose serious health risks if the injectable solution is contaminated.

Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with known quality problems in multiple arterial and radial artery catheter kits. The supplier's medications showed signs of ineffectiveness, and if the sterility of these injectable products was compromised, patients could face serious injury.

Arrow International recalled several PICC (peripherally inserted central catheter) kits and stylets because they contain injectable medications from a supplier with quality issues. The medications—lidocaine, bupivacaine, and saline—may be ineffective or contaminated, which could cause serious injury if used.

Arrow International included local anesthetic drugs (lidocaine and bupivacaine) from a supplier with quality issues into several pacing procedure kits. The supplier's drugs had limited reports of ineffectiveness, and compromised sterility in injectable products could cause serious infection or other life-threatening complications.

Arrow International included anesthetic medications (lidocaine and bupivacaine) and saline solution from a supplier with quality problems in its biopsy system kits. The supplier had reports of drug ineffectiveness, and compromised sterility in injectable products could cause serious injury.

Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with quality problems in multiple anesthesia and nerve block kits. The supplier's products may be ineffective or contaminated, which could cause serious infection or other life-threatening complications if the sterility of these injectable solutions is compromised.